1 The aim of this study was to assess whether the protective eect of ischaemic preconditioning on endothelial function in coronary arteries of the rat involves kinins. 2 Isolated hearts of the rat were exposed to a 30-min low-¯ow ischaemia (¯ow rate of 1 ml min 71 ) followed by 20-min reperfusion, after which coronaries were precontracted with 0.1 mM U-46619, and the response to the endothelium-dependent vasodilator, 5-hydroxytryptamine (5-HT, 10 mM), compared to that of the endothelium-independent vasodilator, sodium nitroprusside (SNP, 3 mM). 3 In untreated hearts, ischaemia-reperfusion diminished selectively 5-HT-induced vasodilatation, compared with time-matched sham hearts. The vasodilatation to SNP was unaected after ischaemiareperfusion. Preconditioning (5 min of zero-¯ow ischaemia followed by 10 min reperfusion) in untreated hearts preserved the vasodilatation produced by 5-HT. -bradykinin (1 nM) 30 min before and lasting throughout the ischaemia protected the endothelium. 6 In conclusion, ischaemic preconditioning aords protection to the endothelial function in coronary resistance arteries of the rat partly by activation of B 1 receptors. Although exogenous BK perfusion can protect the endothelium, B 2 receptors do not play an important role in this protection in the rat isolated heart.
Introduction
Ischaemic preconditioning induced by single or repetitive short periods of ischaemia followed by intermittent reperfusion, renders the heart more resistant to a subsequent longer ischaemic period. This phenomenon limits infarct size (Murry et al., 1986; Cohen et al., 1991) , reduces the risk of ischaemiareperfusion arrhythmias (Shiki & Hearse, 1987; Hagar et al., 1991) , improves recovery of ventricular function (Cohen et al., 1991) , reduces catabolite accumulation and slows ischaemic metabolism (Murry et al., 1990; Reimer et al., 1994) . This cardioprotective eect has been observed in dierent species, including rats (Li & Kloner, 1992; Yellon et al., 1992) , rabbits (Cohen et al., 1991) , dogs (Murry et al., 1986) , pigs (Sack et al., 1993) and man (Yellon et al., 1993) .
Some studies have demonstrated that ischaemia-reperfusion attenuated endothelial function in large coronary vessels (Van Benthuysen et al., 1987; Pearson et al., 1990) and in coronary microvessels (DeFily & Chilian, 1993) . In addition, it has been shown that the bene®cial eect of ischaemic preconditioning is not limited to the cardiomyocytes, but can be observed in endothelial cells in various experimental models including dog resistance coronary arteries in vivo (DeFily & Chilian, 1993) , and coronary circulation of the rat in vitro (Richard et al., 1994; Bouchard & Lamontagne, 1996) . Adenosine (Miura & Iimura, 1993; Liu et al., 1994; Bouchard & Lamontagne, 1996) , ATP sensitive potassium channels (K ATP channels) (Grover, 1994; Parratt & Kane, 1994; Bouchard & Lamontagne, 1996) , and protein kinase C activation have been implicated in the mechanisms of the protection aorded by ischaemic preconditioning.
The contribution of kinins in the protection aorded by ischaemic preconditioning has been studied in the rat isolated heart as well as in dogs and rabbits in vivo. These studies revealed that B 2 -receptor activation is involved in the reduction in both ischaemia and reperfusion-induced arrhythmias (Vegh et al., 1994) and infarct size (Wall et al., 1994; Goto et al., 1995) , and in the improvement of post-ischaemic ventricular recovery by ischaemic preconditioning (Brew et al., 1995) . Numerous studies have demonstrated that exogenous bradykinin perfusion is protective against ischaemia-reperfusion induced ventricular ®brillation (Linz et al., 1990; Vegh et al., 1991) . In addition, it has been shown that exogenous perfusion of bradykinin (BK) and des-Arg 9 -bradykinin (DBK) decreased reperfusion-induced noradrenaline out¯ow and arrhythmias via B 1 -receptors (Chahine et al., 1993) .
However, little is known about the role played by endogenous kinins in the endothelial protective eect of ischaemic preconditioning. Therefore, the initial aim of the present study was to evaluate whether ischaemic preconditioning aords protection against the ischaemic insult to the endothelium of coronary vessels in rat isolated hearts via the kinin pathway. The second aim was to verify whether exogenous kinin perfusion could mimic the bene®cial eects of ischaemic preconditioning against ischaemic insult in these hearts.
Methods

Preparation of hearts
The investigation was performed in accordance with the guidelines from the Canadian Council on Animal Care. Male Sprague-Dawley rats (300 ± 350 g) were narcotized with CO 2 until a complete loss of consciousness and rapidly decapitated. Hearts were rapidly excised and immersed in ice-cold heparintreated buer (10 iu ml 71 ). They were immediately mounted on the Langendor setup and perfused at constant¯ow by means of a digital roller pump. A 20-ml compliance chamber along the perfusion line ensured a continuous¯ow. The¯ow rate was adjusted during the stabilization period to obtain a coronary perfusion pressure of approximately 75 mmHg and was held constant, with the exception of the ischaemic periods during which¯ow was either stopped (zero-¯ow ischaemia) or reduced to 1 ml min 71 (low-¯ow ischaemia). A second adjustment of the¯ow rate was made at the end of the long reperfusion period, before the perfusion of U-46619, to correct any deviation of the coronary perfusion pressure from 75 mmHg, and was held constant thereafter. Flow rate was measured during the whole experiment with an in-line ultrasonic¯ow probe and meter (Transonic Systems Inc., model T106). Perfusion pressure was monitored to calculate coronary resistance. The normal perfusion solution consisted of a modi®ed Krebs-Henseleit buer containing (in mM): NaCl 118, KCl 4, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1, NaHCO 3 24, Dglucose 5 and pyruvate 2. The perfusate was gassed with 95% O 2 -5% CO 2 (pH 7.4) and kept at a constant temperature of 378C. All drugs were administered through a Y connector in the aortic cannula with syringe pumps (Harvard Apparatus, model 11) at one hundredth of the coronary¯ow rate. Adequate mixing of the drugs was ensured by the turbulent ow created in the reverse drop shaped aortic cannula. All concentrations mentioned in the text and ®gures refer to the ®nal concentration after mixing. Coronary perfusion pressure was measured with a pressure transducer connected to a side arm of the aortic perfusion cannula. Isovolumetric left ventricular pressure and its ®rst derivative (dP/dt) was measured by a¯uid ®lled latex balloon inserted into the left ventricle and connected to a second pressure transducer. The volume of the balloon was adjusted to obtain a diastolic pressure between 5 and 10 mmHg. Heart rate was derived from the left ventricular pressure trace by a tachograph. Data were recorded on a polygraph system (Grass Model 79 polygraph).
Experimental protocols
The animals were placed randomly into ®fteen groups ( Figure  1 ). The hearts in all groups were subjected to a 20-min stabilization period. Drugs or vehicle infusion was then started, followed by an additional 15-min perfusion period. The ischaemic groups were subjected to a 15-min sham period, followed by 30 min of partial ischaemia (¯ow rate 1 ml min 71 ) before a 20-min reperfusion period. In the preconditioned groups, the hearts were exposed to 5 min global ischaemia (zero-¯ow) plus 10 min of reperfusion before the 30-min ischaemia and 20-min reperfusion periods. The sham groups were not exposed to ischaemia-reperfusion, but to a timematched normal perfusion. After these periods, coronary arteries were precontracted with 0.1 mM U-46619 administered throughout the end of the experiment. Fifteen minutes after the beginning of U-46619 infusion, the endothelial function was evaluated by the vasodilatation produced by 10 mM 5-hydroxytryptamine (5-HT), whereas coronary smooth muscle function was evaluated with 3 mM sodium nitroprusside (SNP). These infusions were maintained for 10 min, which was long enough to reach a steady state. A washout period of 10 min was allowed between each infusion. Vasodilatation was evaluated by computing % changes in coronary resistance (coronary perfusion pressure divided by coronary¯ow), measured immediately before each drug infusion, and after a new steady state. The concentrations of 5-HT and SNP were determined in preliminary dose-response experiments to produce near-maximal vasodilatation.
Sham, ischaemic, and ischaemic preconditioned hearts were treated with either 10 nM Hoe 140 (icatibant, a selective ]-bradykinin 3 nM (LLDBK, no. 1, 2 and 3), bradykinin 1 nM (BK, no. 4 and 5), desArg 9 -bradykinin 1 nM (DBK, no. 4 and 5), or their respective vehicles (VH)) was started after the 20-min stabilization period, lasted throughout the 30-min low-¯ow ischaemia or a corresponding period, and was stopped upon reperfusion. In all protocols, endothelial and smooth muscle function was evaluated after the 20-min reperfusion period. Coronary arteries were precontracted by a continuous infusion of 0.1 mM U-46619. After 15 min, infusion of 5-HT (10 mM) was started for 10 min. A wash-out period of 10 min was allowed between 5-HT and sodium nitroprusside (SNP, 3 mM, 10 min) infusions. The bottom axis represents the time in min.
starting after the 20-min stabilization period, and lasting throughout the 30-min partial ischaemic period. Drug infusion was stopped upon reperfusion.
In additional experimental series, the eect of an exogenous kinin perfusion was compared with that of ischaemic preconditioning. In these groups, hearts were treated with either 1 nM BK, 1 nM DBK or vehicle starting after the 20-min stabilization period, in order to expose the hearts to 30 min kinin perfusion before ischaemia. The kinin perfusion lasted throughout the 30-min ischaemic period, and was stopped upon reperfusion.
Statistical analysis
Values represent the mean+s.e.mean. Statistical signi®cance of dierences between means was evaluated by a two way analysis of variance followed by a ScheeÂ post-hoc test. In the presence of an interaction between the dierent groups, one way analysis of variance were used for each group. A commercially available software (Systat for Windows version 6.1) was used. Only probability values (P) smaller than 0.05 were considered to be statistically signi®cant.
Drugs
Hoe 140 was kindly provided by Hoechst-Marion-Roussel (Frankfurt, Germany). LLDBK was a generous gift from Dr A. Adam. All other drugs were obtained from Sigma-Aldrich (Mississauga, Ont, Canada). Stock solutions of Hoe 140 (0.1 mM), LLDBK (1 mM), BK (0.9 mM), and DBK (1.12 mM) were prepared in Krebs-Henseleit buer, and further diluted in the same buer. U-46619 (9,11-dideoxy-11a,9a-epoxymethano-prostaglandin F 2a , 28.5 mM) was dissolved in 100% ethanol and diluted in Krebs-Henseleit buer to obtain the desired ®nal concentration. Ethanol (0.003%) at the concentration obtained in the ®nal dilution had no eect on any of the haemodynamic variables studied and on the dilator responses to 5-HT and SNP. All the other drugs were dissolved in KrebsHenseleit buer.
Results
Ischaemic preconditioning groups Vascular function
Untreated groups Coronary resistance measured just before 0.1 mM U-46619 perfusion (n=24) was 5.92+0.29 mmHg min ml
71
, for a coronary¯ow rate of 6.72+0.22 ml min 71 g 71 (mean heart weight of 1.90+0.05 g). Infusion of U-46619 (0.1 mM, n=24) induced a signi®cant (P50.05) vasoconstriction in all groups of hearts (sham, ischaemia, and ischaemic preconditioning, Table 1 ). Perfusion of 10 mM 5-HT produced a diminution in coronary resistance of 725.2+4.8%. Thirty minutes of partial ischaemia signi®cantly diminished the 5-HT induced vasodilatation by more than half (Figure 2a) . One period of ischaemic preconditioning prevented the deleterious eect of ischaemia on endothelium-dependent vasodilatation: the vasodilatation produced by 5-HT in preconditioned hearts was comparable to that observed in hearts not subjected to ischaemia (Figure 2a ). Endotheliumindependent vasodilatation to 3 mM SNP was not aected by ischaemia and was found to be comparable in the three groups (sham, ischaemia and ischaemic preconditioning, Figure 2b ).
Hoe 140 treated groups Blockade of kinin B 2 -receptors with Hoe 140 (10 nM) was accompanied by a small but nonsigni®cant increase in coronary resistance when measured just before 0.1 mM U-46619 perfusion (Hoe 140 treated vs untreated hearts, P40.05, Table 1 ). The perfusion rate was 5.57+0.32 ml min 71 g 71 (mean heart weight of 2.18+0.06 g). Infusion of U-46619 (0.1 mM, n=27) induced a signi®cant (P50.05) vasoconstriction in all Hoe 140 treated groups (Table 1) . Vasodilatation produced by 10 mM 5-HT (720.3+4.2% in sham hearts, n=7) was almost totally abolished in the ischaemic group (Figure 2c ). Ischaemic preconditioning in Hoe 140 treated hearts was still able to prevent completely the deleterious eect of ischaemia on 5-HT-induced vasodilatation (Figure 2c ). Vasodilatation to 3 mM SNP was comparable in the three Hoe 140 treated groups (sham, ischaemia and ischaemic preconditioning, Figure 2d ).
LLDBK treated groups Blockade of kinin B 1 receptors with LLDBK produced no signi®cant increase in coronary resistance when measured just before 0.1 mM U-46619 perfusion (LLDBK treated vs untreated hearts, P40.05, Table  1 ). The perfusion rate was 5.75+0.31 ml min 71 g 71 (mean heart weight of 2.16+0.08 g). Infusion of U-46619 (0.1 mM, n=17) induced a signi®cant (P50.05) vasoconstriction in all three groups (Table 1) . Vasodilatation produced by 10 mM 5-HT (735.7+4.5% in sham hearts, n=5) was practically abolished in the ischaemic group (Figure 2e ). Ischaemic preconditioning in LLDBK treated hearts was unable to prevent the deleterious eect of ischaemia on 5-HT-induced vasodilatation (Figure 2e ). Vasodilatation to 3 mM SNP was comparable in the three LLDBK treated groups (sham, ischaemia and ischaemic preconditioning, Figure 2f ).
Myocardial function
The inotropic and lusitropic characteristics of Hoe 140 and LLDBK pretreated hearts were comparable to those of untreated hearts: dP/dt max values measured before the 30-min low-¯ow ischaemia were 1980+449 (n=16), 1453+45 (n=20) and 1532+104 mmHg s 71 (n=12), and the dP/dt min values 934+120 (n=16), 966+42 (n=20) and 1041+65 mmHg s 71 (n=12), for untreated, Hoe 140 and LLDBK pretreated hearts, respectively. Low-¯ow ischaemia was accompanied by a severe reduction in dP/dt max ( Figure 3 ) and in dP/dt min (Figure 4 ) in all groups. Ischaemic preconditioning improved dP/dt max and dP/dt min recovery during ischaemia, particularly during the last 20 min of ischaemia, in LLDBK pretreated (Figures 3  and 4) and Hoe 140 pretreated (Figures 3 and 4) , but not in untreated hearts. Ischaemic preconditioning improved the post-ischaemic recovery of dP/dt max ( Figure 3 ) and dP/dt min ( Figure 4 ) in LLDBK pretreated (Figures 3 and 4) and Hoe 140 pretreated (Figures 3 and 4) , but not in untreated hearts (Figures 3 and 4) .
Exogenous kinins groups Vascular function
BK treated groups Perfusion with BK (1 nM) produced no signi®cant eect on coronary resistance when measured just before the 30-min ischaemic period (0.7+2.7% variation of coronary resistance, n=12). The perfusion rate in BK treated hearts was 6.11+0.32 ml min 71 g 71 (mean heart weight of 2.14+0.14 g). Infusion of U-46619 (0.1 mM, n=12) induced a signi®cant (P50.05) vasoconstriction in all BK treated hearts (Table 1) . Thirty minutes of low-¯ow ischaemia signi®cantly diminished the 5-HT-induced vasodilatation by more than half in untreated hearts (Figure 5a ). Treatment with BK, starting 30 min before ischaemia, preserved the vasodilatation produced by 10 mM 5-HT in ischaemic hearts (Figure 5a ). Vaso- ,des-Arg 9 ]-bradykinin (LLDBK, 3 nM) (c) pretreated hearts. Number of ischaemic and ischaemic preconditioning hearts were 8 and 8 for untreated; 7 and 13 for Hoe 140; and 6 and 6 for LLDBK pretreated hearts, respectively. *P50.05 compared with ischaemic hearts. dilatation to 3 mM SNP was comparable in all BK treated hearts (Figure 5b ). DBK treated groups DBK perfusion (1 nM) produced no signi®cant eect on coronary resistance when measured just before the 30-min ischaemic period (3.5+3.0% variation of coronary resistance, n=12). The perfusion rate in DBK treated hearts was 6.41+0.54 ml min 71 g 71 (mean heart weight of 2.14+0.13 g). Infusion of U-46619 (0.1 mM, n=12) induced a signi®cant (P50.05) vasoconstriction in all DBK-treated hearts (Table 1) . Thirty minutes of low-¯ow ischaemia halved the 5-HT-induced vasodilatation in untreated hearts ( Figure  5c ). Treatment with DBK, starting 30 min before ischaemia, preserved the vasodilatation produced by 10 mM 5-HT in ischaemic hearts (Figure 5c ). Vasodilatation to 3 mM SNP was comparable in all DBK treated hearts (Figure 5d ).
Myocardial function
The dP/dt max values measured before the 30-min low-¯ow ischaemia were 1483+71 and 1600+63 mmHg s 71 , and the dP/dt min values 942+88 and 1180+116 mmHg s 71 , for BK 1 nM and DBK 1 nM pretreated hearts, respectively. In both groups, pretreatment with exogenous kinins, either DBK or BK 30-min before ischaemia, had no eect on ischaemic or post-ischaemic recovery of dP/ dt max and dP/dt min (data not shown).
Discussion
In the present study, the contribution of kinins in the protective eect of ischaemic preconditioning on myocardial and endothelial functions of the rat heart was assessed. The major ®ndings are (1) that ischaemic preconditioning with a single short period of ischaemia prevents endothelial dysfunction produced by ischaemia-reperfusion in rat hearts via activation of B 1 receptors, but not B 2 receptors, and (2) both DBK and BK perfusions starting 30 min before ischaemia can mimic the bene®cial eect of ischaemic preconditioning on endothelial function in rat coronary arteries.
Eect of preconditioning on ischaemic dysfunction
In the present study, the ischaemic conditions (¯ow rate and duration) were selected in order to observe a selective ]-bradykinin (3 nM, LLDBK) (c) pretreated hearts. Number of ischaemic and ischaemic preconditioning hearts were 8 and 8 for untreated; 7 and 13 for Hoe 140; and 6 and 6 for LLDBK pretreated hearts, respectively. *P50.05 compared with ischaemic hearts. endothelial dysfunction. This was con®rmed by the fact that the endothelium-dependent and NO-mediated (Mankad et al. 1991) vasodilatation of coronary arteries to 5-HT was drastically decreased after the ischaemia-reperfusion insult, whereas the same vessels retained the ability to dilate to SNP, an endothelium-independent vasodilator. It was demonstrated earlier (Bouchard & Lamontagne, 1996) that ischaemic preconditioning prevents the reduction in the vasodilatation to 5-HT after ischaemia-reperfusion, suggesting that ischaemic preconditioning can protect endothelial function in coronary arteries. Such a protection was observed in the present study. A protective eect of ischaemic preconditioning was also observed with canine epicardial coronary arteries (DeFily & Chilian, 1993) , and in rat isolated left coronary arteries in vitro (Richard et al., 1994) .
The upper and lower limits of the dP/dt signal, dP/dt max and dP/dt min , which represent the capacity of the ventricle to contract during systole and its ability to relax during diastole, were used to evaluate the contractile function of the hearts. These variables recovered rapidly and completely within the 20-min reperfusion period. Furthermore, ischaemic preconditioning failed to improve post-ischaemic ventricular recovery. The inability of ischaemic preconditioning to improve ventricular recovery is most probably due to the fact that the present ischaemic conditions were too mild to depress severely the contractile function, leaving little room for improvement.
Role of B 2 receptors in ischaemic preconditioning
BK has often been shown to be an endogenous mediator of the protection aorded by ischaemic preconditioning (Parratt et al., 1995) . Some investigators have demonstrated that the B 2 receptor antagonist, Hoe 140, prevents the protective eect of ischaemic preconditioning on ventricular arrhythmias in dogs in vivo (Vegh et al., 1994) , on infarct size in rabbits in vivo (Wall et al., 1994) , and contractile function in isolated rat hearts (Brew et al., 1995) . However, to the best of our knowledge, little is known about the role played by endogenous kinins in the endothelial protective eect of ischaemic preconditioning. Therefore, we tested whether B 2 receptor activation was involved in the protection aorded by ischaemic preconditioning to the endothelium. Hoe 140 was chosen for its high selectivity for B 2 receptors. Furthermore, the concentration used was above those corresponding to the pA 2 values reported in the literature . The protective eect of ischaemic preconditioning on endothelial function was not aected by Hoe 140, as re¯ected by the comparable endothelium-dependent vasodilatation to 5-HT in both Hoe 140-treated preconditioned and sham groups. Therefore, these data suggest that B 2 receptor activation is not involved in the protection aorded by ischaemic preconditioning, against endothelial dysfunction observed following ischaemia-reperfusion.
In the present experimental conditions, Hoe 140 pretreatment seems to improve myocardial recovery in the preconditioned group, but this may rather be due to a slightly depressed myocardial recovery observed in the Hoe 140 treated ischaemic group. Thus, these data suggest that B 2 receptor activation may be required for a full post-ischaemic ventricular recovery under the present conditions.
Role of B 1 receptors in ischaemic preconditioning
Recently, it has been shown that the protective eect against ischaemia obtained by either BK or DBK perfusion is mediated via the activation of B 1 receptors (Chahine et al., 1993) . However, at present, the role played by B 1 receptor activation in the protective action of ischaemic preconditioning remains unknown. Therefore, we tested, using a potent and highly selective B 1 receptor antagonist , whether the activation of B 1 receptors is involved in ischaemic preconditioning. In the LLDBK treated preconditioned group, the vasodilatation to 5-HT was halved whereas the vasodilatation to SNP was not signi®cantly dierent from that observed in the sham group. These data suggest that an endogenously produced B 1 -receptor agonist plays a role in the endothelial protection aorded by ischaemic preconditioning.
In the present experimental conditions, myocardial recovery was improved in the LLDBK treated preconditioned group, compared with the LLDBK treated ischaemic group. Once again, this phenomenon is probably due to the depressed myocardial recovery observed in the LLDBK treated ischaemic group, and suggests that B 1 receptor activation may also be needed for rapid post-ischaemic ventricular recovery.
Protective eect of exogenous kinins
To con®rm the contribution of kinins in the endothelial protection aorded by ischaemic preconditioning, the eect of exogenous perfusion with low concentration of kinins on the endothelial function following ischaemia-reperfusion was studied. Two kinins were compared: BK and DBK, both were perfused 30 min before ischaemia. Both kinins prevented the ischaemia-induced reduction in the vasodilatation to 5-HT. Thus, these data suggest that both BK and DBK can mimic the protective eect of ischaemic preconditioning on the endothelial function.
In contrast to the endothelial function, neither BK nor DBK were able to improve ischaemic and post-ischaemic recovery of dP/dt max and dP/dt min . As discussed earlier, this is probably due to the fact that a 30-min 1 ml min 71 ischaemia, although sucient to alter the endothelial function, is not severe enough to impair ventricular recovery.
The mechanisms by which kinins could exert a protective eect are numerous (Parratt et al., 1995) . Bradykinin, released from ischaemic tissues can act directly on B 2 receptors or can be metabolized into DBK and act on B 1 receptors (Linz et al., 1996) . We have recently observed that the protective eect of BK on the endothelial function in the rat isolated heart can be blocked by LLDBK (unpublished observation), suggesting that B 1 receptors might be implicated in the protective eect of BK. B 1 receptors could be expressed during the ischaemia as an induction of B 1 receptors has been found to occur in pathological conditions such as anoxia (Marceau & Regoli, 1991) . Activation of B 2 and possibly B 1 receptors could stimulate the endothelial production of NO and prostacyclin both of which have been linked to K ATP channel activation (Bouchard et al., 1994; Miyoshi et al., 1994) . It has been recently demonstrated that inhibition of K ATP channels with glibenclamide reduces the endothelial protection aorded by ischaemic preconditioning (Bouchard & Lamontagne, 1996) . The exact mechanisms by which K ATP channel activation protects the endothelium remain unknown, but several hypotheses have been proposed (Bouchard & Lamontagne, 1996) .
Alternatively, both B 1 and B 2 receptors activate phospholipase C to release inositol 1,4,5-trisphosphate and 1,2-diacylglycerol. The latter compound in combination with intracellular calcium then causes the translocation and activation of PKC. Activated PKC may phosphorylate secondary eectors, which would be responsible for the protective eects of ischaemic preconditioning (Speechly-Dick et al., 1994; Brew et al., 1995) .
It may be argued that the protective eect of BK could be based on an increase in coronary¯ow, which would increase glucose uptake and washing of deleterious catabolic wastes. However, an increase in coronary¯ow is certainly not the only contributor of these bene®cial eects. Previous studies have shown that BK at a low concentration, without any eect on coronary¯ow, still prevented the deleterious eect of ischaemia-reperfusion (Brew et al., 1995; Linz et al., 1995) . In addition, our study demonstrated protection to the endothelium without a discernible increase in coronarȳ ow.
In conclusion, these data suggest that ischaemic preconditioning aords protection to the endothelial function against subsequent ischaemic insult in the intact coronary circulation of the rat. The reduced protective eect of ischaemic preconditioning in presence of LLDBK suggests that this protection may be mediated partially by B 1 receptor activation. The lack of an inhibitory action of Hoe 140 on ischaemic preconditioning suggests that B 2 receptors do not play a role in the endogenous protection of the endothelial function. Exogenous perfusion of BK or DBK can aord protection to endothelial function against the deleterious eect of ischaemia-reperfusion.
